Fair Market Value vs. Current Market Leverage

by Rob Besse | Feb 4 | Distribution, Strategy

INSIGHTS Home 9 Tag: Manufacturer   •   Fair Market Value vs. Current Market Leverage How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for...

Archbow Consulting Strengthens Leadership Team with Key Promotions

by Team Archbow | Jan 29 | Industry News

INSIGHTS Home 9 Author archive for Team Archbow Team Archbow   •   Archbow Consulting Strengthens Leadership Team with Key Promotions These strategic appointments reflect Archbow’s continued growth and commitment to delivering...

ECRM 2025: Key Trends & Opportunities

by Team Archbow | Jan 14 | Distribution, Industry News, Market Access, Strategy

INSIGHTS Home 9 Tag: Biotech   •   ECRM 2025: Key Trends & Opportunities Archbow Consulting uncovered valuable pharma insights at ECRM including optimizing supply chain solutions and refining market access strategies. ECRM 2025: Key...

Navigating the Evolving Pharma Landscape: A Year in Review

by Team Archbow | Dec 17 | Distribution, HUBs, Market Access, Patient Access, Specialty Pharmacy, Technology

INSIGHTS Home 9 Tag: Biotech   •   Navigating the Evolving Pharma Landscape: A Year in Review Archbow Consulting’s insights served as a valuable resource for navigating a year of evolving trends. Navigating the Evolving Pharma Landscape...

Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation

by Team Archbow | Nov 21 | HUBs, Market Access, Patient Access, Strategy

INSIGHTS Home 9 Tag: Biotech   •   Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation New whitepaper from Archbow Consulting is available for download now. Top Five Reasons Why an Innovation Investment in Patient...